about
Intradermal skin test with diabetes specific antigens in patients with type 1 diabetesHypovitaminosis D is independently associated with metabolic syndrome in obese patients.Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease.Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes.No protective effect of calcitriol on beta-cell function in recent-onset type 1 diabetes: the IMDIAB XIII trial.Altered glucose homeostasis is associated with increased serum apelin levels in type 2 diabetes mellitus.Glycated hemoglobin for the diagnosis of diabetes and prediabetes: Diagnostic impact on obese and lean subjects, and phenotypic characterization.Hypovitaminosis D in recent onset rheumatoid arthritis is predictive of reduced response to treatment and increased disease activity: a 12 month follow-up study.Association of FTO polymorphisms with early age of obesity in obese Italian subjectsNo effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.Association of RXR-Gamma Gene Variants with Familial Combined Hyperlipidemia: Genotype and Haplotype Analysis.The vitamin D receptor functional variant rs2228570 (C>T) does not associate with type 2 diabetes mellitus.Vitamin E and nicotinamide have similar effects in maintaining residual beta cell function in recent onset insulin-dependent diabetes (the IMDIAB IV study)Natural resistance of human beta cells toward nitric oxide is mediated by heat shock protein 70.T cell reactivity to human insulinoma cell line (CM) antigens in patients with type 1 diabetes.The "Sapienza University Mortality and Morbidity Event Rate (SUMMER) study in diabetes": Study protocol.Beta-cell markers and autoantigen expression by a human insulinoma cell line: similarities to native beta cells.Affected sib-pair analysis of the GLUT1 glucose transporter gene locus in non-insulin-dependent diabetes mellitus (NIDDM): evidence for no linkage.The Arg282Ser missense mutation in APOA5 gene determines a reduction of triglyceride and LDL-cholesterol in children, together with low serum levels of apolipoprotein A-V.Vitamin D Supplementation and Non-Alcoholic Fatty Liver Disease: Present and Future.Metabolic and immune parameters at clinical onset of insulin-dependent diabetes: a population-based study. IMDIAB Study Group. Immunotherapy Diabetes.Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study).Combination of nicotinamide and steroid versus nicotinamide in recent-onset IDDM. The IMDIAB II Study.No effect of oral insulin on residual beta-cell function in recent-onset type I diabetes (the IMDIAB VII). IMDIAB Group.Therapy with proton pump inhibitors in patients with type 2 diabetes is independently associated with improved glycometabolic control.The G972R variant of the insulin receptor substrate-1 gene impairs insulin signaling and cell differentiation in 3T3L1 adipocytes; treatment with a PPARgamma agonist restores normal cell signaling and differentiation.Subclinical vascular alterations in young adults with type 1 diabetes detected by arterial tonometry.Continuous glucose monitoring during the European Soccer cup semifinal, Italy against Holland.Inhaled insulin in type 1 diabetes.Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus.Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease.Oral glucose tolerance test in Italian overweight/obese children and adolescents results in a very high prevalence of impaired fasting glycaemia, but not of diabetes.Biokinetics of buccal spray insulin in patients with type 1 diabetes.3,5,3'-triiodothyronine (T3) is a survival factor for pancreatic beta-cells undergoing apoptosis.Tumor necrosis factor alpha (TNFalpha) and its soluble receptor p75 (sTNF-R p75) in familial combined hyperlipidemia (FCHL).Clinical phenotype and beta-cell autoimmunity in Italian patients with adult-onset diabetes.Search for genetic variants of the SYNTAXIN 1A (STX1A) gene: the -352 A>T variant in the STX1A promoter associates with impaired glucose metabolism in an Italian obese population.Circulating IL-8 levels are increased in patients with type 2 diabetes and associated with worse inflammatory and cardiometabolic profile.High prevalence of diabetes-specific autoimmunity in first-degree relatives of Sardinian patients with type 1 diabetes.Phenotypical heterogeneity linked to adipose tissue dysfunction in patients with Type 2 diabetes.
P50
Q28362310-34839B35-D7A1-4ECB-8ACD-7C9670C69296Q30352761-507F8034-C091-4C5F-937B-3CC4F9F7FE18Q33719929-FA3804F1-09F4-43A3-BF97-39A332D2B575Q33958775-25AFE1EA-5713-4AF6-9367-42D52159150CQ34084512-6D5786F7-E08F-480E-A7E1-30A58FA86A5EQ34507329-ED4905AA-0B62-4B9E-BCD9-09C639C8A4C0Q34976677-16247B83-E54E-4554-8D97-475BC6166EC6Q35215520-A916FAAB-E9A6-4457-9A3A-76B85CFA810EQ35791647-C1355F7C-1A22-46BA-AD32-476FE784C0EDQ36063593-954BBC1E-A9CF-4CB7-80CF-B1D94E4E7E61Q37261316-2B8480E3-77C0-4270-B901-60AB86683A29Q38847885-0B667E6A-A6A5-417F-9DCB-024C4157F856Q40881078-7973C1E4-F6E3-448A-ADB3-89CA38C6A25DQ40888704-840AF565-C7EE-4D30-B81F-40254C2D5A31Q40937806-3E69F590-F980-4E23-86CE-9B99E7192A39Q41026601-6AA651CA-7328-4177-908E-CDDF255612FBQ41189044-A382718D-F92C-4755-B635-A54E3F0CAC68Q41662020-99134383-4028-44AE-B891-1C518E6AEBA9Q41716157-CB42DDA0-83CC-42B2-BDF3-6E0D7084D255Q41998000-624B1E3F-F27B-4923-BABC-2BC18F8D41D8Q42462724-592A1BD3-F877-49E9-B84E-CCEF190C4329Q42478441-B1C7D1C3-770D-4DA6-9612-EBE5DC8D1775Q42492805-53C9BBE1-1AB0-4990-8FFD-162E04CB8FA8Q42493380-2B2A9CA2-9713-4700-AE79-5B6BD7889AE7Q42608530-1F49C7A4-1B78-4533-A29A-F5D7D2D3401CQ42805429-C9B2AC9F-34A3-4DD4-BF88-30D27C98D08BQ43259262-020B9CED-354A-48EB-8E32-43B3258BC112Q43554909-FB87C2DB-99E7-4E37-A8B8-D153A2BB7E8DQ43656485-F949D2DA-45FF-48D6-876F-E6475FBB8CD0Q43674589-8DE76907-1717-40A5-BE5F-72DEEC915381Q45187039-E5017BC5-9C18-4240-BACE-B8051AA4ABBBQ45983204-24EB1E66-3EFD-4915-8009-B6738C98CE2AQ46575879-4129AF20-CD4E-4D62-AA43-BCDD4701CF93Q46602332-5613A18D-E849-4D27-8E04-EB956A02DECCQ46626917-48C9B36E-EDCC-4A9F-A914-8DC76AA74871Q46960670-845A38C6-1BA6-4D3B-990C-4B0588B39CCBQ46970006-0D58584A-7DEB-45C7-96F2-43E74CCA8057Q47289442-16EEB65A-DF37-46ED-A524-050635465F14Q47665973-4A3F1AD1-2AAD-415E-9B75-DD0E4BFBD94DQ47732191-F7EE96F2-DF53-4B87-ACBF-510AD08687D7
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Maria Gisella Cavallo
@ast
Maria Gisella Cavallo
@en
Maria Gisella Cavallo
@es
Maria Gisella Cavallo
@nl
Maria Gisella Cavallo
@sl
type
label
Maria Gisella Cavallo
@ast
Maria Gisella Cavallo
@en
Maria Gisella Cavallo
@es
Maria Gisella Cavallo
@nl
Maria Gisella Cavallo
@sl
prefLabel
Maria Gisella Cavallo
@ast
Maria Gisella Cavallo
@en
Maria Gisella Cavallo
@es
Maria Gisella Cavallo
@nl
Maria Gisella Cavallo
@sl
P106
P1153
7003877094
P21
P31
P496
0000-0001-6630-8049